Dan S Zuckerman, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-2711 Fax: 208-381-4025 |
Dr. Olga Derman, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 W. Fort St., # 111, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1319 |
Dr. Kerry P Pulver, MD,PHD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-3131 Fax: 208-367-4860 |
Norman Zuckerman, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-2711 |
Nicholas Tyler Gorden, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-3131 |
William H Kreisle, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-2709 |
Theodore A Walters, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-2711 Fax: 208-381-4025 |
Shane Ahlers, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-2711 |
Anuhya Kommalapati, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-2711 |
Andrew S Pierson, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-3131 Fax: 208-367-4860 |
News Archive
The Food and Drug Administration today granted 510(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc.
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
Although Uganda had many achievements to celebrate on the anniversary of its independence on Wednesday, the country must "focus on independence on the individual level," especially among women affected by HIV/AIDS in the country, Milly Nattimba of the Makerere University School of Public Health writes in a New Vision opinion piece.
Superheroes, Minions, pint-sized princesses and a cowboy invaded the hallways of St. Joseph's Children's Hospital in Tampa today. Some came on foot, others arrived in little red wagons and wheelchairs, and all were in search of Halloween goodies.
› Verified 3 days ago